MARIAN DEAMES: Open Payments
NPI 1891100863 · LAMBERTVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 28 payments from 16 companies in 2025. Trend: 2023 $262 · 2024 $339 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $77 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Exact Sciences Corporation | 2 | $45 |
| PFIZER INC. | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
| Lilly USA, LLC | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: AIRSUPRA, REXULTI, Cologuard Collection Kit, Ozempic, TRELEGY ELLIPTA, GEMTESA, VRAYLAR, ZEPBOUND.
Industry payments across MI — which companies pay providers there.
